Clinical Trials
18 trialsNCT06167486 2026-03-09
SG2918 For Advanced Malignant Tumors
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1 Active not recruiting
NCT07038005 2026-02-09
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT07016490 2026-01-28
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT07043751 2026-01-21
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT07338838 2026-01-14
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT07032298 2025-07-25
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT05868876 2025-03-03
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
Akeso
Phase 1 Recruiting
NCT06691360 2024-11-15
AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
Akeso
Phase 1 Not yet recruiting
NCT05653284 2024-08-13
A Study of AK130 in Patients With Advanced Malignant Tumors
Akeso
Phase 1 Completed
NCT05082545 2024-06-04
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
Atridia Pty Ltd.
Phase 1 Completed
NCT05877924 2024-03-26
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NovaRock Biotherapeutics, Ltd
Phase 1 Recruiting
NCT05193721 2024-03-20
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT06226363 2024-01-26
Phase I Study of LNF1901 in Advanced Malignant Tumors
Shandong New Time Pharmaceutical Co., LTD
Phase 1 Not yet recruiting
NCT05728541 2023-02-17
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04708210 2022-10-12
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Unknown
NCT05198817 2022-06-28
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT05110807 2022-02-14
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT04128085 2019-12-16
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown